Rapid test kit for simultaneous detection of cardiac troponin I (cTnI), myoglobin, and creatine kinase-MB (CK-MB) markers. Designed for quick diagnosis of acute myocardial infarction and cardiac injury in clinical and emergency settings. Delivers results in minutes to support timely patient manageme...
Manufactured by
NewScen Coast Bio-Pharmaceutical Co., Ltd.
China
NewScen Coast Bio-Pharmaceutical Co., Ltd., established in 2003, is a leading POCT manufacturer listed on China's NEEQ (Stock Code: 872334). The company produces rapid diagnostic products covering cardiac markers, infection, tumor, and infectious disease testing, serving over 110 domestic medical institutions and exporting to 20+ countries. In 2019, the company established China's first automated microfluidic chip production line for immunoassay applications.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Jiangsu Medomics Medical Technology Co.,Ltd.
China · 1 relevant product
Shandong Kanghua Biotechnology Co.,Ltd.
China · 2 relevant products
Lumigenex (Suzhou) Co., Ltd
China · 3 relevant products
72 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →13 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 113 closest product alternatives
Jiangsu Medomics Medical Technology Co.,Ltd. · China
A combination rapid test kit for simultaneous detection of cardiac troponin I (cTnI), myoglobin (Myo), and creatine kinase-MB (CK-MB). This multiplex test supports cardiac biomarker assessment for heart attack and myocardial injury detection.
Shandong Kanghua Biotechnology Co.,Ltd. · China
Immunofluorescence-based combined test kit for simultaneous detection of cardiac biomarkers cTnI, CK-MB, and myoglobin. Designed for rapid cardiac injury assessment in acute coronary syndrome diagnosis and risk stratification. Enables multi-marker analysis from a single sample for improved clinical decision-making.
Lumigenex (Suzhou) Co., Ltd · China
A quantitative test kit for simultaneous measurement of cardiac troponin I (cTnI), creatine kinase-MB (CK-MB), and myoglobin (MYO) levels in patient samples using TRFIA methodology.
110 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products